ZA725519B - Medicines containing 2-pyridones - Google Patents

Medicines containing 2-pyridones

Info

Publication number
ZA725519B
ZA725519B ZA725519A ZA725519A ZA725519B ZA 725519 B ZA725519 B ZA 725519B ZA 725519 A ZA725519 A ZA 725519A ZA 725519 A ZA725519 A ZA 725519A ZA 725519 B ZA725519 B ZA 725519B
Authority
ZA
South Africa
Prior art keywords
pyridones
medicines containing
medicines
Prior art date
Application number
ZA725519A
Inventor
F Eiden
R Gren
Original Assignee
Thiemann Gmbh H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thiemann Gmbh H filed Critical Thiemann Gmbh H
Publication of ZA725519B publication Critical patent/ZA725519B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA725519A 1971-08-13 1972-08-11 Medicines containing 2-pyridones ZA725519B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2140712A DE2140712A1 (en) 1971-08-13 1971-08-13 MEDICINAL PRODUCTS CONTAINING 2-PYRIDONES

Publications (1)

Publication Number Publication Date
ZA725519B true ZA725519B (en) 1973-04-25

Family

ID=5816721

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA725519A ZA725519B (en) 1971-08-13 1972-08-11 Medicines containing 2-pyridones

Country Status (6)

Country Link
BE (1) BE787523A (en)
DE (1) DE2140712A1 (en)
FR (1) FR2150750B1 (en)
GB (1) GB1388001A (en)
NL (1) NL7210798A (en)
ZA (1) ZA725519B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006244072B2 (en) * 2005-05-10 2012-09-20 Intermune, Inc. Pyridone derivatives for modulating stress-activated protein kinase system
US8304413B2 (en) 2008-06-03 2012-11-06 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
AR092742A1 (en) 2012-10-02 2015-04-29 Intermune Inc ANTIFIBROTIC PYRIDINONES
EP3126362B1 (en) 2014-04-02 2022-01-12 Intermune, Inc. Anti-fibrotic pyridinones

Also Published As

Publication number Publication date
FR2150750A1 (en) 1973-04-13
BE787523A (en) 1973-02-12
DE2140712A1 (en) 1973-02-15
GB1388001A (en) 1975-03-19
NL7210798A (en) 1973-02-15
FR2150750B1 (en) 1976-08-20

Similar Documents

Publication Publication Date Title
ZA722506B (en) Tetrachlorophthalide compounds
IL39181A0 (en) Insulin product
IE35991L (en) Camphor-containing pharmaceutical composition
AU4916772A (en) Benzimidazolyl-2-aminoimidazolines
IE35910B1 (en) Pharmaceutical composition
ZA725519B (en) Medicines containing 2-pyridones
AU4209872A (en) Container-agitator
GB1369721A (en) Organotin compounds
AU4775472A (en) New polyepoxide-polysiloxane compounds
AU4604872A (en) Medicines with ulcer-healing effect
IL38792A0 (en) New aminoisoquinolines
ZA721363B (en) Pharmaceutical composition
JPS5123342A (en) Kazariito no seizoho
ZA721612B (en) Cyclic compounds
JPS51110123A (en) gasorinkikan no judokugasuboshihoho
CA34756S (en) Tablet
CA34279S (en) Tablet
CA34749S (en) Tablet
CA34758S (en) Tablet
CA34746S (en) Tablet
CA34757S (en) Tablet
CA34243S (en) Bottle
CA33771S (en) Bottle
CA34346S (en) Bottle
CA34347S (en) Bottle